FDA OKs new chronic myeloid leukemia drug
WASHINGTON, Oct. 30 (UPI) -- The U.S. Food and Drug Administration has approved Tasigna (nilotinib) capsules for treatment of Philadelphia chromosome positive chronic myeloid leukemia.

| Stories | Photos | People | Comments |
View Caption